Specifically, there were quantitative differences between the expressions of IRS1, PIK3R1, SLC2A1, SLC2A3, and SLC2A4 among the patients with GDM during pregnancy and at 1-year postpartum, i.e., in the two studied groups differing in the degree of insulin resistance. The gene discussed is SLC2A1; the disease is Insulin resistance.